MENU
TBPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Theravance Biopharma (TBPH) Ownership - Who owns Theravance Biopharma?
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
477.01M
P/E Ratio
N/A
Total Cash
88.35M
Projected Growth
N/A
Total Debt
49.82M
Revenue
64.38M
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash/Share
1.77
Total Debt/Equity
N/A
Revenue/Share
1.32 USD as % of share price
Fundamentals
TBPH
Capitalization
477M
P/E Ratio
N/A
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash
88.4M
Total Cash/Share
1.77
Total Debt
49.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.32%
Revenue
64.4M
ROE
N/A
Book Value
176M
P/B Ratio
2.72
Cash Flow
N/A
Earnings
-1.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
5.02
Current Revenue Per Employee
193340.20
Dividends Per Share - Security
N/A
EBITDA
-38.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-15.33
Shares Held By Institutions
1.3B
Shares Outstanding - Current
50M
Total Liabilities
179M
Total Volume MTD
N/A
Value
N/A
Gain YTD
1.382
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of small molecule pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com